Baris Bingol is a distinguished research and drug development leader at Genentech, currently serving as Director and Senior Principal Scientist (Group Head) since October 2022, focusing on target identification and validation for nervous system disorders. Prior experience includes roles at MIT Picower Learning and Memory as a Postdoctoral Associate under Morgan Sheng, studying synaptic kinases and developing imaging assays, and various positions at Genentech from 2010 to 2017, where Baris contributed significantly to research on the ubiquitin-proteasome system and published numerous articles in prestigious journals. Baris holds a Bachelor of Science degree in Molecular Biology and Genetics from Bilkent Universität and a PhD in Molecular and Cellular Neuroscience from the California Institute of Technology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices